Septic polyarthritis with Ureaplasma urealyticum in a patient with prolonged agammaglobulinemia and B-cell aplasia after allogeneic HSCT and rituximab pretreatment [2]

Bone Marrow Transplantation

Volumn 40, Issue 6, 2007, Pages 597-598

  Arber, C ^a   Buser, A ^a   Heim, D ^a   Weisser, M ^a   Tyndall, A ^a   Tichelli, A ^a   Passweg, J ^a   Gratwohl, A ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; DOXORUBICIN; DOXYCYCLINE; ETOPOSIDE; FLUDARABINE; GANCICLOVIR; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PIPERACILLIN PLUS TAZOBACTAM; PREDNISOLONE; PREDNISONE; RITUXIMAB; STEROID; VINCRISTINE; VORICONAZOLE;

ACUTE KIDNEY FAILURE; ADULT; AGAMMAGLOBULINEMIA; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; B CELL LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CANCER RELAPSE; CANCER STAGING; CASE REPORT; CLINICAL FEATURE; CONNECTIVE TISSUE DISEASE; CYTOMEGALOVIRUS INFECTION; CYTOREDUCTIVE SURGERY; DIFFERENTIAL DIAGNOSIS; DISEASE DURATION; DISEASE SEVERITY; GRAFT VERSUS HOST REACTION; GRAM NEGATIVE INFECTION; HUMAN; LETTER; LUNG ASPERGILLOSIS; LYMPHOCYTOPENIA; MALE; MULTIPLE CYCLE TREATMENT; PNEUMONIA; POLYARTHRITIS; POLYMERASE CHAIN REACTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; TREATMENT DURATION; UREAPLASMA UREALYTICUM; WHOLE BODY RADIATION;

ADULT; AGAMMAGLOBULINEMIA; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; ARTHRITIS, INFECTIOUS; B-LYMPHOCYTES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOMA, B-CELL; MALE; UREAPLASMA INFECTIONS; UREAPLASMA UREALYTICUM;

EID: 34548535304     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705766     Document Type: Letter

References (10)

1. Shortt J, Spencer A. Adjuvant rituximab causes prolonged hypogammaglobulinaemia following autologous stem cell transplant for non-Hodgkin's lymphoma. Bone Marrow Transplant 2006; 38: 433-436.
2. Goldberg SL, Pecora AL, Alter RS, Kroll MS, Rowley SD, Waintraub SE et al. Unusual viral infections (progressive multifocal leukoencephalopathy and cytomegalovirus disease) after high-dose chemotherapy with autologous blood stem cell rescue and peritransplantation rituximab. Blood 2002; 99: 1486-1488.
3. Buser AS, Heim D, Bucher C, Tichelli A, Gratwohl A, Passweg JR. High-dose chemotherapy using BEAM for tumor debulking without stem cell support followed by early allogeneic reduced intensity conditioning transplantation to induce a graft-versus-lymphoma effect in patients with high risk or refractory lymphoma. Bone Marrow Transplant 2004; 33: 1011-1014.
4. Asmar BI, Andresen J, Brown WJ. Ureaplasma urealyticum arthritis and bacteremia in agammaglobulinemia. Pediatr Infect Dis J 1998; 17 73-76.
5. Held G, Poschel V, Pfreundschuh M. Rituximab for the treatment of diffuse large B-cell lymphomas. Expert Rev Anticancer Ther 2006; 6: 1175-1186.
6. Van Besien K. The evolving role of autologous and allogeneic stem cell transplantation in follicular lymphoma. Blood Rev 2006; 20: 235-244.
7. McLaughlin P, Grillo-Lopez AJ, Link BK, Levy R, Czuczman MS, Williams ME et al. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: Half of patients respond to a four-dose treatment program. J Clin Oncol 1998; 16: 2825-2833.
8. Horwitz SM, Negrin RS, Blume KG, Breslin S, Stuart MJ, Stockerl-Goldstein KE et al. Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma. Blood 2004; 103: 777-783.
9. Cartron G, Blasco H, Paintaud G, Watier H, Le Guellec C. Pharmacokinetics of rituximab and its clinical use: Thought for the best use? Crit Rev Oncol Hematol 2007; 62: 43-52.
10. Nishio M, Fujimoto K, Yamamoto S, Endo T, Sakai T, Obara M et al. Delayed redistribution of CD27, CD40 and CD80 positive B cells and the impaired in vitro immunoglobulin production in patients with non-Hodgkin lymphoma after rituximab treatment as an adjuvant to autologous stem cell transplantation. Br J Haematol 2007; 137 349-354.